About Medizinische Fakultät der Universität Rostock
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Celgene
1
Medtronic Bakken Research Center
1
Novartis Vaccines
1
University of Erlangen-Nürnberg Medical School
1
Clinical Trials at Medizinische Fakultät der Universität Rostock
During the past decade, Medizinische Fakultät der Universität Rostock conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects
2011-09-01
2011-10-01
Completed
126
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Medizinische Fakultät der Universität Rostock
According to Clinical.Site data, the most researched conditions in "Medizinische Fakultät der Universität Rostock" are
"Heart Disease" (1 trials), "Influenza" (1 trials), "Multiple Myeloma" (1 trials) and "Rectal Neoplasms" (1 trials). Many other conditions were trialed in "Medizinische Fakultät der Universität Rostock" in a lesser frequency.
Clinical Trials Intervention Types at Medizinische Fakultät der Universität Rostock
Most popular intervention types in "Medizinische Fakultät der Universität Rostock" are "Drug" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "5-FU" (1 trials), "5-FU and oxaliplatin" (1 trials), "Implantable Defibrillator" (1 trials), "Lenalidomide and low-dose dexamethasone" (1 trials) and "Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medizinische Fakultät der Universität Rostock
The vast majority of trials in "Medizinische Fakultät der Universität Rostock" are
4 trials for "All" genders.
Clinical Trials Status at Medizinische Fakultät der Universität Rostock
Currently, there are NaN active trials in "Medizinische Fakultät der Universität Rostock".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Medizinische Fakultät der Universität Rostock,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medizinische Fakultät der Universität Rostock, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".